Overview

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

Status:
Completed
Trial end date:
2013-04-13
Target enrollment:
Participant gender:
Summary
This study is to evaluate safety and efficacy of ASP1941 after 24 week administration to diabetic patients.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin